Prevalence of Human Papillomavirus Genotypes in High-Grade Cervical Precancer and Invasive Cervical Cancer From Cancer Registries Before and After Vaccine Introduction in the United States
Document Type
Article
Publication Date
7-21-2021
Publication Title
Cancer
Abstract
Background: US population-based cancer registries can be used for surveillance of human papillomavirus (HPV) types found in HPV-associated cancers. Using this framework, HPV prevalence among high-grade cervical precancers and invasive cervical cancers were compared before and after HPV vaccine availability. Methods: Archived tissue from 2 studies of cervical precancers and invasive cervical cancers diagnosed from 1993-2005 (prevaccine) were identified from 7 central cancer registries in Florida; Hawaii; Iowa; Kentucky; Louisiana; Los Angeles County, California; and Michigan; from 2014 through 2015 (postvaccine) cases were identified from 3 registries in Iowa, Kentucky, and Louisiana. HPV testing was performed using L1 consensus polymerase chain reaction analysis. HPV-type–specific prevalence was examined grouped by hierarchical attribution to vaccine types: HPV 16, 18, HPV 31, 33, 45, 52, 58, other oncogenic HPV types, and other types/HPV negative. Generalized logit models were used to compare HPV prevalence in the prevaccine study to the postvaccine study by patient age, adjusting for sampling factors. Results: A total of 676 precancers (328 prevaccine and 348 postvaccine) and 1140 invasive cervical cancers (777 prevaccine and 363 postvaccine) were typed. No differences were observed in HPV-type prevalence by patient age between the 2 studies among precancers or invasive cancers. Conclusions: The lack of reduction in vaccine-type prevalence between the 2 studies is likely explained by the low number of cases and low HPV vaccination coverage among women in the postvaccine study. Monitoring HPV-type prevalence through population-based strategies will continue to be important in evaluating the impact of the HPV vaccine.
First Page
3614
Last Page
3621
PubMed ID
34289090
Volume
127
Issue
19
Publisher
Wiley; American Cancer Society
Recommended Citation
Mix, Jacqueline M.; Saraiya, Mona; Thompson, Trevor D.; Querec, Troy D.; Greek, April; Tucker, Thomas C.; Peters, Edward S.; Lynch, Charles F.; Hernandez, Brenda Y.; Copeland, Glenn; Goodman, Marc T.; and Unger, Elizabeth R., "Prevalence of Human Papillomavirus Genotypes in High-Grade Cervical Precancer and Invasive Cervical Cancer From Cancer Registries Before and After Vaccine Introduction in the United States" (2021). School of Public Health Faculty Publications. 55.
https://digitalscholar.lsuhsc.edu/soph_facpubs/55
10.1002/cncr.33582